Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Graphical Abstract Similar content being viewed by others Introduction Glucagon-like peptide-1 (GLP-1) receptor agonists and sodium-glucose cotransporter 2 inhibitors (SGLT2) are key treatments for type 2 diabetes that improve cardiovascular and renal outcomes [1,2,3]
GLP-1 drugs add a new dimension to that complexity
Nicotine replacement therapy (NRT) remains a cornerstone of smoking cessation support and is available in multiple formulations including patches, gum, lozenges, inhalators, nasal spray, and mouth spray
In fact, select studies have recently demonstrated low-dose IR may have therapeutic benefit in select disease states such as heart failure and sarcoidosis [83, 84]
US$ 21.95
US$ 27.75
US$ 21.63
US$ 26.86
US$ 25.55
US$ 20.11
US$ 27.15
US$ 21.58
